{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:55:03Z","timestamp":1770782103658,"version":"3.50.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejogrb.2014.10.020","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T14:48:19Z","timestamp":1414680499000},"page":"146-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European\/Canadian healthcare providers"],"prefix":"10.1016","volume":"183","author":[{"given":"Kai J.","family":"Buhling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Dermout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katty","family":"Ardaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Marions","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.10.020_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","article-title":"Unintended pregnancy: worldwide levels, trends, and outcomes","volume":"41","author":"Singh","year":"2010","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0020","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318273eb56","article-title":"Preventing unintended pregnancies by providing no-cost contraception","volume":"120","author":"Peipert","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/AOG.0b013e3182a91f45","article-title":"Twenty-four-month continuation of reversible contraception","volume":"122","author":"O\u2019neil-Callahan","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0035","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0040","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0045","series-title":"UK medical eligibility for contraceptive use","author":"Faculty of the Royal College of Obstetricians and Gynaecologists","year":"2009"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0050","series-title":"U.S. medical eligibility criteria for contraceptive use, 2010","author":"Centers for Disease Control and Prevention","year":"2010"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2010.01.010","article-title":"Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women","volume":"81","author":"Lyus","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","article-title":"ACOG practice bulletin no. 121: long-acting reversible contraception: implants and intrauterine devices","volume":"118","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/13625187.2012.700744","article-title":"A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women","volume":"17","author":"Black","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.contraception.2009.08.002","article-title":"Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists\u2019 knowledge and attitudes","volume":"81","author":"Madden","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0075","series-title":"World contraceptive use 2013","author":"United Nations","year":"2013"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0080","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2013.06.005","article-title":"Global survey of healthcare practitioners\u2019 beliefs and practices around intrauterine contraceptive method use in nulliparous women","volume":"88","author":"Black","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0095","series-title":"2010 Sexually transmitted diseases surveillance: STDs in adolescents and young adults","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13625187.2011.558222","article-title":"Use of the levonorgestrel releasing-intrauterine system in nulliparous women\u2014a non-interventional study in Sweden","volume":"16","author":"Marions","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.contraception.2003.11.008","article-title":"Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study","volume":"69","author":"Suhonen","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0110","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.contraception.2011.05.012","article-title":"Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas","volume":"84","author":"Bahamondes","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/13814780409044540","article-title":"Complications of the intrauterine device in nulliparous and parous women","volume":"10","author":"Veldhuis","year":"2004","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/00016349709024611","article-title":"How effectively do copper intrauterine devices prevent ectopic pregnancy?","volume":"76","author":"Skjeldestad","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0125","first-page":"107","article-title":"Population-based ectopic pregnancy trends, 1993\u20132007","volume":"42","author":"Trabert","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/aje\/kwf190","article-title":"Risk factors for ectopic pregnancy: a comprehensive analysis based on a large case-control, population-based study in France","volume":"157","author":"Bouyer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(05)67103-6","article-title":"Ectopic pregnancy","volume":"366","author":"Farquhar","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.contraception.2012.06.002","article-title":"Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling\u2014results of an international survey in 10 countries","volume":"86","author":"Gemzell-Danielsson","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0145","series-title":"New developments in intrauterine contraception: use of intrauterine contraception in the United States","author":"Association of Reproductive Health Professionals","year":"2004"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0150","series-title":"Abstract and poster presented at the Association of Reproductive Health Professionals (ARHP) annual meeting","article-title":"A multicenter, randomized, Phase III study of two low-dose levonorgestrel intrauterine systems (LNG-IUSs) for contraception: a subgroup analysis of efficacy and safety in nulliparous versus parous women","author":"Drosman","year":"2013"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/ejc.8.3.150.155","article-title":"Analysis of risk factors associated with uterine perforation by intrauterine devices","volume":"8","author":"Caliskan","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0010-7824(02)00417-1","article-title":"Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?","volume":"67","author":"Harrison-Woolrych","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02699200802253706","article-title":"Experience of IUD\/IUS insertions and clinical performance in nulliparous women\u2014a pilot study","volume":"13","author":"Brockmeyer","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2014.10.020_bib0170","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514005442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514005442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:33:33Z","timestamp":1759556013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514005442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"alternative-id":["S0301211514005442"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.10.020","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European\/Canadian healthcare providers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}